Maytansine in refractory childhood acute lymphocytic leukemia: a Pediatric Oncology Group study.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D004351:Drug Resistance; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008453:Maytansine / Q000008:administration & dosage* / Q000009:adverse effects; D010078:Oxazines / Q000008:administration & dosage*
D010078:Oxazines; D008453:Maytansine